Drugs / Thiosulfate
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 1 | NCT01114958 Background | Sep 2009 → May 2013 | lung neoplasm, metastatic neoplasm | University of California, San Diego | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Thiosulfate | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01114958 ↗ |
| Route | Intravenous | “Thiosulfate (9 g/m\^2), is given concurrently with cisplatin as an intravenous push over 15-20 minutes followed by a 6-hour intravenous infusion of thiosulfate (12 g/m\^2).” NCT01114958 ↗ |